Skip to main content Accessibility help
Hostname: page-component-888d5979f-22jsc Total loading time: 1.395 Render date: 2021-10-26T07:04:15.142Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Chapter 7 - Common Risk Factors and Prevention

from Section 2 - Clinical Epidemiology and Risk Factors

Published online by Cambridge University Press:  16 May 2019

Michael Brainin
Donau-Universität Krems, Austria
Wolf-Dieter Heiss
Universität zu Köln
Get access
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)


O'Donnell, MJ, Chin, SL, Rangarajan, S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet 2016; 388: 761–75.CrossRefGoogle ScholarPubMed
Feigin, VL, Roth, GA, Naghavi, M, et al. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol 2016; 15: 913–24.CrossRefGoogle ScholarPubMed
Kurth, T, Moore, S, Gaziano, J, et al. Healthy lifestyle and the risk of stroke in women. Arch Intern Med 2006; 166: 1403–9.CrossRefGoogle ScholarPubMed
Chiuve, SE, Rexrode, KM, Spiegelman, D, et al. Primary prevention of stroke by healthy lifestyle. Circulation 2008; 118: 947–54.CrossRefGoogle ScholarPubMed
Zhang, Y, Tuomilehto, J, Jousilahti, P, et al. Lifestyle factors on the risks of ischemic and hemorrhagic stroke. Arch Intern Med 2011; 171: 1811–18.CrossRefGoogle ScholarPubMed
Lv, J, Yu, C, Guo, Y, et al. Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population. J Am Coll Cardiol 2017; 69: 1116–25.CrossRefGoogle ScholarPubMed
Larsson, SC, Akesson, A, Wolk, A. Healthy diet and lifestyle and risk of stroke in a prospective cohort of women. Neurology 2014; 83: 1699–704.CrossRefGoogle Scholar
Larsson, SC, Åkesson, A, Wolk, A. Primary prevention of stroke by a healthy lifestyle in a high-risk group. Neurology 2015; 84: 2224–8.CrossRefGoogle Scholar
Feigin, VL, Norrving, B, Mensah, GA. Primary prevention of cardiovascular disease through population-wide motivational strategies: insights from using smartphones in stroke prevention. BMJ Glob Health 2017; 2: e000306.CrossRefGoogle ScholarPubMed
Rogers, MA, Lemmen, K, Kramer, R, Mann, J, Chopra, V. Internet-delivered health interventions that work: systematic review of meta-analyses and evaluation of website availability. J Med Internet Res 2017; 19: e90.CrossRefGoogle ScholarPubMed
Wolf, PA, D'Agostino, RB, Kannel, WB, Bonita, R, Belanger, AJ. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 1988; 259: 1025–9.CrossRefGoogle ScholarPubMed
Kawachi, I, Colditz, GA, Stampfer, MJ, et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993; 269: 232–6.CrossRefGoogle ScholarPubMed
Honjo, K, Iso, H, Tsugane, S, et al. The effects of smoking and smoking cessation on mortality from cardiovascular disease among Japanese: pooled analysis of three large-scale cohort studies in Japan. Tob Control 2010; 19: 50–7.CrossRefGoogle Scholar
Mons, U, Müezzinler, A, Gellert, C, et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ 2015; 350: h1551.CrossRefGoogle ScholarPubMed
Shinton, R, Beevers, G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989; 298: 789–94.CrossRefGoogle ScholarPubMed
Teunissen, LL, Rinkel, GJ, Algra, A, van Gijn, J. Risk factors for subarachnoid hemorrhage: a systematic review. Stroke 1996; 27: 544–9.CrossRefGoogle ScholarPubMed
Ariesen, MJ, Claus, SP, Rinkel, GJ, Algra, A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke 2003; 34: 2060–5.CrossRefGoogle ScholarPubMed
Price, AJ, Wright, FL, Green, J, et al. Differences in risk factors for 3 types of stroke: UK prospective study and meta-analyses. Neurology 2018; 90: e298–306.CrossRefGoogle ScholarPubMed
Howard, G, Wagenknecht, LE, Burke, GL, et al. Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. JAMA 1998; 279: 119–24.CrossRefGoogle ScholarPubMed
Lee, PN, Forey, BA. Environmental tobacco smoke exposure and risk of stroke in nonsmokers: a review with meta-analysis. J Stroke Cerebrovasc Dis 2006; 15: 190201.CrossRefGoogle ScholarPubMed
Håheim, LL, Holme, I, Hjermann, I, Leren, P. Smoking habits and risk of fatal stroke: 18 years follow up of the Oslo Study. J Epidemiol Community Health 1996; 50: 621–4.CrossRefGoogle ScholarPubMed
WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Ischemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet 1996; 348: 498505.CrossRef
Stead, LF, Perera, R, Bullen, C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012; 11: CD000146.Google ScholarPubMed
Hughes, JR, Stead, LF, Hartmann-Boyce, J, Cahill, K, Lancaster, T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2014; 1: CD000031.Google Scholar
Cahill, K, Lindson-Hawley, N, Thomas, KH, Fanshawe, TR, Lancaster, T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Sys Rev 2016; 5: CD006103.Google Scholar
Barth, J, Critchley, J, Bengel, J. Psychosocial interventions for smoking cessation in patients with coronary heart disease. Cochrane Database Syst Rev 2008; 1: CD006886.Google Scholar
Whittaker, R, McRobbie, H, Bullen, C, Rodgers, A, Gu, Y. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev 2016; 4: CD006611.Google ScholarPubMed
Taylor, GMJ, Dalili, MN, Semwal, M, et al. Internet-based interventions for smoking cessation. Cochrane Database Syst Rev 2017; 9: CD007078.Google ScholarPubMed
Larsson, SC, Wallin, A, Wolk, A, Markus, HS. Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis. BMC Med 2016; 14: 178.CrossRefGoogle ScholarPubMed
de Lange, DW, Hijmering, ML, Lorsheyd, A, et al. Rapid intake of alcohol (binge drinking) inhibits platelet adhesion to fibrinogen under flow. Alcohol Clin Exp Res 2004; 28: 1562–8.CrossRefGoogle ScholarPubMed
Truelsen, T, Gronbaek, M, Schnohr, P, Boysen, G. Intake of beer, wine, and spirits and risk of stroke: the Copenhagen city heart study. Stroke 1998; 29: 2467–72.CrossRefGoogle ScholarPubMed
Hillbom, M, Numminen, H, Juvela, S. Recent heavy drinking of alcohol and embolic stroke. Stroke 1999; 30: 2307–12.CrossRefGoogle ScholarPubMed
Guiraud, V, Amor, MB, Mas, JL, Touzé, E. Triggers of ischemic stroke: a systematic review. Stroke 2010; 41: 2669–77.CrossRefGoogle ScholarPubMed
Wannamethee, SG, Shaper, AG. Patterns of alcohol intake and risk of stroke in middle-aged British men. Stroke 1996; 27: 1033–9.CrossRefGoogle ScholarPubMed
Kiyohara, Y, Kato, I, Iwamoto, H, Nakayama, K, Fujishima, M. The impact of alcohol and hypertension on stroke incidence in a general Japanese population. The Hisayama Study. Stroke 1995; 26: 368–72.CrossRefGoogle Scholar
Roerecke, M, Kaczorowski, J, Tobe, SW, et al. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health 2017; 2: e108–20.CrossRefGoogle ScholarPubMed
Djoussé, L, Levy, D, Benjamin, EJ, et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am J Cardiol 2004; 93: 710–13.CrossRefGoogle ScholarPubMed
Kurth, T, Gaziano, J, Berger, K, et al. Body mass index and the risk of stroke in men. Arch Intern Med 2002; 162: 2557–62.CrossRefGoogle ScholarPubMed
Jood, K, Jern, C, Wilhelmsen, L, Rosengren, A. Body mass index in mid-life is associated with a first stroke in men: a prospective population study over 28 years. Stroke 2004; 35: 2764–9.CrossRefGoogle ScholarPubMed
Kurth, T, Gaziano, J, Rexrode, K, et al. Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation 2005; 111: 1992–8.CrossRefGoogle ScholarPubMed
Kroll, ME, Green, J, Beral, V, et al. Adiposity and ischemic and hemorrhagic stroke: prospective study in women and meta-analysis. Neurology 2016; 87: 1473–81.CrossRefGoogle ScholarPubMed
Hu, G, Tuomilehto, J, Silventoinen, K, et al. Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch Intern Med 2007; 167: 1420–7.CrossRefGoogle ScholarPubMed
Song, YM, Sung, J, Davey Smith, G, Ebrahim, S. Body mass index and ischemic and hemorrhagic stroke: a prospective study in Korean men. Stroke 2004; 35: 831–6.CrossRefGoogle ScholarPubMed
Emerging Risk Factors Collaboration, Wormser, D, Kaptoge, S, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011; 377: 1085–95.Google ScholarPubMed
Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects), Lu, Y, Hajifathalian, K, et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet 2014; 383: 970–83.Google ScholarPubMed
Neter, J, Stam, B, Kok, F, Grobbee, D, Geleijnse, J. Influence of weight reduction on blood pressure a meta-analysis of randomized controlled trials. Hypertension 2003; 42: 878–84.CrossRefGoogle ScholarPubMed
Look AHEAD Research Group. Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial. Diabetologia 2015; 58: 1803–13.
Shaw, K, Gennat, H, O'Rourke, P, Del Mar, C. Exercise for overweight or obesity. Cochrane Database Syst Rev 2006; 4: CD003817.Google Scholar
Li, J, Siegrist, J. Physical activity and risk of cardiovascular disease – a meta-analysis of prospective cohort studies. Int J Environ Res Public Health 2012; 9: 391407.CrossRefGoogle ScholarPubMed
Wahid, A, Manek, N, Nichols, M, et al. Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis. J Am Heart Assoc 2016; 5: e002495.CrossRefGoogle ScholarPubMed
Kyu, HH, Bachman, VF, Alexander, LT, et al. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013. BMJ 2016; 354: i3857.CrossRefGoogle ScholarPubMed
Lee, C, Folsom, A, Blair, S. Physical activity and stroke risk: a meta-analysis. Stroke 2003; 34: 2475–81.CrossRefGoogle ScholarPubMed
Kubota, Y, Iso, H, Yamagishi, K, et al. Daily total physical activity and incident stroke: the Japan Public Health Center-Based Prospective Study. Stroke 2017; 48: 1730–6.CrossRefGoogle ScholarPubMed
Bennett, DA, Du, H, Clarke, R, et al. Association of physical activity with risk of major cardiovascular diseases in Chinese men and women. JAMA Cardiol 2017; 2: 1349–58.CrossRefGoogle ScholarPubMed
Wendel-Vos, GC, Schuit, AJ, Feskens, EJ, et al. Physical activity and stroke: a meta-analysis of observational data. Int J Epidemiol 2004; 33: 787–98.CrossRefGoogle ScholarPubMed
Hu, G, Sarti, C, Jousilahti, P, et al. Leisure time, occupational, and commuting physical activity and the risk of stroke. Stroke 2005; 36: 1994–9.CrossRefGoogle ScholarPubMed
Gong, J, Xu, Y, Chen, X, et al. Persistent effect at 30-month post intervention of a community-based randomized trial of KM2H(2) in reducing stroke and heart attack among senior hypertensive patients. Int J Behav Nutr Phys Act 2018; 15: 1.CrossRefGoogle ScholarPubMed
Arija, V, Villalobos, F, Pedret, R, et al. Effectiveness of a physical activity program on cardiovascular disease risk in adult primary health-care users: the “Pas-a-Pas” community intervention trial. BMC Public Health 2017; 17: 576.CrossRefGoogle ScholarPubMed
Newman, AB, Dodson, JA, Church, TS, et al. Cardiovascular events in a physical activity intervention compared with a successful aging intervention: the LIFE Study Randomized Trial. JAMA Cardiol 2016; 1: 568–74.CrossRefGoogle Scholar
Jørgensen, T, Jacobsen, RK, Toft, U, et al. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ 2014; 348: g3617.CrossRefGoogle ScholarPubMed
Cornelissen, VA, Smart, NA. Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc 2013; 2: e004473.CrossRefGoogle ScholarPubMed
Carlsson, AC, Ärnlöv, J, Sundström, J, et al. Physical activity, obesity and risk of cardiovascular disease in middle-aged men during a median of 30 years of follow-up. Eur J Prev Cardiol 2016; 23: 359–65.CrossRefGoogle ScholarPubMed
Ding, EL, Mozaffarian, D. Optimal dietary habits for the prevention of stroke. Semin Neurol 2006; 26: 1123.CrossRefGoogle ScholarPubMed
Hankey, GJ. The role of nutrition in the risk and burden of stroke: an update of the evidence. Stroke 2017; 48: 3168–74.CrossRefGoogle Scholar
Aune, D, Giovannucci, E, Boffetta, P, et al. Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality – a systematic review and dose-response meta-analysis of prospective studies. Int J Epidemiol 2017; 46: 1029–56.CrossRefGoogle ScholarPubMed
Miller, V, Mente, A, Dehghan, M, et al. Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study. Lancet 2017; 390: 2037–49.CrossRefGoogle ScholarPubMed
Aune, D, Keum, N, Giovannucci, E, et al. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies. BMJ 2016; 353: i2716.CrossRefGoogle ScholarPubMed
Chowdhury, R, Stevens, S, Gorman, D, et al. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ 2012; 345: e6698.CrossRefGoogle ScholarPubMed
Mozaffarian, D, Rimm, EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006; 296: 1885–99.CrossRefGoogle ScholarPubMed
Aburto, NJ, Ziolkovska, A, Hooper, L, et al. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ 2013; 346: f1326.CrossRefGoogle ScholarPubMed
Adler, AJ, Taylor, F, Martin, N, et al. Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev 2014; 12: CD009217.Google Scholar
Graudal, NA, Hubeck-Graudal, T, Jurgens, G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev 2017; 4: CD004022.Google ScholarPubMed
Sacks, FM, Svetkey, LP, Vollmer, WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 310.CrossRefGoogle ScholarPubMed
Vinceti, M, Filippini, T, Crippa, A, et al. Meta-analysis of potassium intake and the risk of stroke. J Am Heart Assoc 2016; 5: e004210.CrossRefGoogle ScholarPubMed
Aburto, NJ, Hanson, S, Gutierrez, H, et al. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ 2013; 346: f1378.CrossRefGoogle ScholarPubMed
Tian, DY, Tian, J, Shi, CH, et al. Calcium intake and the risk of stroke: an updated meta-analysis of prospective studies. Asia Pac J Clin Nutr 2015; 24: 245–52.Google ScholarPubMed
Larsson, SC, Orsini, N, Wolk, A. Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. Am J Clin Nutr 2012; 95: 362–6.CrossRefGoogle ScholarPubMed
Ding, M, Bhupathiraju, SN, Satija, A, van Dam, RM, Hu, FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation 2014; 129: 643–59.CrossRefGoogle Scholar
Zhang, C, Qin, YY, Wei, X, et al. Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies. Eur J Epidemiol 2015; 30: 103–13.CrossRefGoogle ScholarPubMed
Yuan, S, Li, X, Jin, Y, Lu, J. Chocolate consumption and risk of coronary heart disease, stroke, and diabetes: a meta-analysis of prospective studies. Nutrients 2017; 9: e688.CrossRefGoogle ScholarPubMed
Salehi-Abargouei, A, Maghsoudi, Z, Shirani, F, Azadbakht, L. Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases – incidence: a systematic review and meta-analysis on observational prospective studies. Nutrition 2013; 29: 611–18.CrossRefGoogle ScholarPubMed
Rosato, V, Temple, NJ, La Vecchia, C, et al. Mediterranean diet and cardiovascular disease: a systematic review and meta-analysis of observational studies. Eur J Nutr 2017 (published online ahead of print November 25, 2017). Accessed February 3, 2018.Google ScholarPubMed
Liyanage, T, Ninomiya, T, Wang, A, et al. Effects of the Mediterranean diet on cardiovascular outcomes – a systematic review and meta-analysis. PLoS One 2016; 11: e0159252.CrossRefGoogle ScholarPubMed
Estruch, R, Ros, E, Salas-Salvadó, J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368: 1279–90.CrossRefGoogle ScholarPubMed
Howard, B, Van Horn, L, Hsia, J, et al. Low-fat dietary pattern and risk of cardiovascular disease: the women's health initiative randomized controlled dietary modification trial. JAMA 2006; 295: 655–66.Google ScholarPubMed
Lisabeth, L, Bushnell, C. Stroke risk in women: the role of menopause and hormone therapy. Lancet Neurol 2012; 11: 8291.CrossRefGoogle ScholarPubMed
Wassertheil-Smoller, S, Hendrix, SL, Limacher, M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003; 289: 2673–84.CrossRefGoogle ScholarPubMed
Gartlehner, G, Patel, SV, Feltner, C, et al. Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: evidence report and systematic review for the US Preventive Services Task Force. JAMA 2017; 318: 2234–49.CrossRefGoogle ScholarPubMed
Marjoribanks, J, Farquhar, C, Roberts, H, Lethaby, A, Lee, J. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2017; 1: CD004143.Google ScholarPubMed
Cuzick, J, Sestak, I, Bonanni, B, et al. Selective oestrogen receptor modulators in prevention of breast cancers: an updated meta-analysis of individual participant data. Lancet 2013; 381: 1827–34.CrossRefGoogle ScholarPubMed
Barrett-Connor, E, Mosca, L, Collins, P, et al. Raloxifene Use for The Heart (RUTH) Trial Investigators. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 2006; 355: 125–37.CrossRefGoogle ScholarPubMed
Bushnell, CD, Goldstein, LB. Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis. Neurology 2004; 63: 1230–3.CrossRefGoogle ScholarPubMed
Cummings, SR, Ensrud, K, Delmas, PD, et al. Lasofoxifene in postmenopausal women with osteoporosis. N Engl J Med 2010; 362: 686–96.CrossRefGoogle ScholarPubMed
Lewington, S, Clarke, R, Qizilbash, N, Peto, R, Collins, R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–13.Google ScholarPubMed
Lawes, CM, Bennett, DA, Feigin, VL, Rodgers, A. Blood pressure and stroke: an overview of published reviews. Stroke 2004; 35: 1024.CrossRefGoogle ScholarPubMed
Ettehad, D, Emdin, CA, Kiran, A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016; 387: 957–67.CrossRefGoogle ScholarPubMed
Reboussin, DM, Allen, NB, Griswold, ME, et al. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2017; 71: e116–35.Google Scholar
Lonn, EM, Bosch, J, López-Jaramillo, P, et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med 2016; 374: 2009–20.CrossRefGoogle ScholarPubMed
Whelton, PK, Carey, RM, Aronow, WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017; 71: e127–248.Google Scholar
Staessen, J, Fagard, R, Thijs, L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The systolic hypertension in Europe (syst-eur) trial investigators. Lancet 1997; 350: 757–64.CrossRefGoogle ScholarPubMed
Weiss, J, Freeman, M, Low, A, et al. Benefits and harms of intensive blood pressure treatment in adults aged 60 years or older: a systematic review and meta-analysis. Ann Intern Med 2017; 166: 419–29.CrossRefGoogle ScholarPubMed
Beckett, NS, Peters, R, Fletcher, AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887–98.CrossRefGoogle ScholarPubMed
Emerging Risk Factors Collaboration, Sarwar, N, Gao, P, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215–22.Google ScholarPubMed
Zhang, C, Zhou, YH, Xu, CL, Chi, FL, Ju, HN. Efficacy of intensive control of glucose in stroke prevention: a meta-analysis of data from 59,197 participants in 9 randomized controlled trials. PLoS One 2013; 8: e54465.CrossRefGoogle ScholarPubMed
Griffin, SJ, Leaver, JK, Irving, GJ. Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes. Diabetologia 2017; 60: 1620–9.CrossRefGoogle ScholarPubMed
Castilla-Guerra, L, Fernandez-Moreno, MDC, Leon-Jimenez, D, Carmona-Nimo, E. Antidiabetic drugs and stroke risk. Current evidence. Eur J Intern Med 2018; 48: 15.CrossRefGoogle ScholarPubMed
Newman, JD, Schwartzbard, AZ, Weintraub, HS, Goldberg, IJ, Berger, JS. Primary prevention of cardiovascular disease in diabetes mellitus. J Am Coll Cardiol 2017; 70: 883–93.CrossRefGoogle ScholarPubMed
Look AHEAD Research Group, Wing, RR, Bolin, P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013; 369: 145–54.Google ScholarPubMed
UK Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care 1997; 20: 1683–7.
de Vries, FM, Denig, P, Pouwels, KB, Postma, MJ, Hak, E. Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis. Drugs 2012; 72: 2365–73.CrossRefGoogle ScholarPubMed
Prospective studies collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 1995; 346: 1647–53.
Yaghi, S, Elkind, MS. Lipids and cerebrovascular disease: research and practice. Stroke 2015; 46: 3322–8.CrossRefGoogle ScholarPubMed
Wang, X, Dong, Y, Qi, X, Huang, C, Hou, L. Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis. Stroke 2013; 44: 1833–9.CrossRefGoogle ScholarPubMed
Prospective Studies Collaboration, Lewington, S, Whitlock, G, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007; 370: 1829–39.Google ScholarPubMed
Collins, R, Reith, C, Emberson, J, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016; 388: 2532–61.CrossRefGoogle ScholarPubMed
Chou, R, Dana, T, Blazina, I, Daeges, M, Jeanne, TL. Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US Preventive Services Task Force. JAMA 2016; 316: 2008–24.CrossRefGoogle ScholarPubMed
McKinney, JS, Kostis, WJ. Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials. Stroke 2012; 43: 2149–56.CrossRefGoogle ScholarPubMed
Mammen, AL, Amato, AA. Statin myopathy: a review of recent progress. Curr Opin Rheumatol 2010; 22: 644–50.CrossRefGoogle ScholarPubMed
Mills, EJ, O'Regan, C, Eyawo, O, et al. Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients. Eur Heart J 2011; 32: 1409–15.CrossRefGoogle ScholarPubMed
Jakob, T, Nordmann, AJ, Schandelmaier, S, Ferreira-González, I, Briel, M. Fibrates for primary prevention of cardiovascular disease events. Cochrane Database Syst Rev 2016; 11: CD009753.Google ScholarPubMed
Schandelmaier, S, Briel, M, Saccilotto, R, et al. Niacin for primary and secondary prevention of cardiovascular events. Cochrane Database Syst Rev 2017; 6: CD009744.Google ScholarPubMed
Karatasakis, A, Danek, BA, Karacsonyi, J, et al. Effect of PCSK9 inhibitors on clinical outcomes in patients with hypercholesterolemia: a meta-analysis of 35 randomized controlled trials. J Am Heart Assoc 2017; 6: pii: e006910.CrossRefGoogle ScholarPubMed
HPS3/TIMI55–REVEAL Collaborative Group, Bowman, L, Hopewell, JC, et al. Effects of anacetrapib in patients with atherosclerotic vascular disease. N Engl J Med 2017; 377: 1217–27.Google ScholarPubMed
Wolf, PA, Abbott, RD, Kannel, WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983–8.CrossRefGoogle ScholarPubMed
Go, AS, Hylek, EM, Phillips, KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370–5.CrossRefGoogle ScholarPubMed
Lamassa, M, Di Carlo, A, Pracucci, G, et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project). Stroke 2001; 32: 392–8.CrossRefGoogle Scholar
Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 2007; 69: 546–54.
Stroke Risk in Atrial Fibrillation Working Group. Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke 2008; 39: 1901–10.
Kirchhof, P, Benussi, S, Kotecha, D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37: 2893–962.CrossRefGoogle ScholarPubMed
Hart, RG, Pearce, LA, Aguilar, MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857–67.CrossRefGoogle ScholarPubMed
Connolly, SJ, Ezekowitz, MD, Yusuf, S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139–51.CrossRefGoogle ScholarPubMed
Granger, CB, Alexander, JH, McMurray, JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981–92.CrossRefGoogle ScholarPubMed
Patel, MR, Mahaffey, KW, Garg, J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883–91.CrossRefGoogle ScholarPubMed
Giugliano, RP, Ruff, CT, Braunwald, E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013; 369: 2093–104.CrossRefGoogle ScholarPubMed
Ruff, CT, Giugliano, RP, Braunwald, E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014; 383: 955–62.CrossRefGoogle ScholarPubMed
Rasmussen, LH, Larsen, TB, Graungaard, T, Skjøth, F, Lip, GY. Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis. BMJ 2012; 345: e7097.CrossRefGoogle ScholarPubMed
Pollack, CV, Jr., Reilly, PA, Eikelboom, J, et al. Idarucizumab for dabigatran reversal. N Engl J Med 2015; 373: 511–20.CrossRefGoogle ScholarPubMed
Connolly, SJ, Milling, TJ, Jr., Eikelboom, JW, et al. Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med 2016; 375: 1131–41.CrossRefGoogle ScholarPubMed
Loke, YK, Brown, JW, Kwok, CS, Niruban, A, Myint, PK. Association of obstructive sleep apnea with risk of serious cardiovascular events: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2012; 5: 720–8.CrossRefGoogle ScholarPubMed
Somers, VK, White, DP, Amin, R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008; 118: 1080–111.CrossRefGoogle Scholar
Pamidi, S, Tasali, E. Obstructive sleep apnea and type 2 diabetes: is there a link? Front Neurol 2012; 3: 126.CrossRefGoogle Scholar
Thomasouli, MA, Brady, EM, Davies, MJ, Hall, AP, Khunti, K, Morris, DH, et al. The impact of diet and lifestyle management strategies for obstructive sleep apnoea in adults: a systematic review and meta-analysis of randomised controlled trials. Sleep Breath 2013; 17: 925–35.CrossRefGoogle ScholarPubMed
Montesi, SB, Edwards, BA, Malhotra, A, Bakker, JP. The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Clin Sleep Med 2012; 8: 587–96.Google ScholarPubMed
Abuzaid, AS, Al Ashry, HS, Elbadawi, A, et al. Meta-analysis of cardiovascular outcomes with continuous positive airway pressure therapy in patients with obstructive sleep apnea. Am J Cardiol 2017; 120: 693–9.CrossRefGoogle ScholarPubMed
Lee, KK, Miller, MR, Shah, ASV. Air pollution and stroke. J Stroke 2018; 20: 211.CrossRefGoogle ScholarPubMed
Solenkova, NV, Newman, JD, Berger, JS, et al. Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure. Am Heart J 2014; 168: 812–22.CrossRefGoogle Scholar
Shah, AS, Lee, KK, McAllister, DA, et al. Short term exposure to air pollution and stroke: systematic review and meta-analysis. BMJ 2015; 350: h1295.CrossRefGoogle ScholarPubMed
Ljungman, PL, Mittleman, MA. Ambient air pollution and stroke. Stroke 2014; 45: 3734–41.CrossRefGoogle ScholarPubMed
Noubiap, JJ, Essouma, M, Bigna, JJ. Targeting household air pollution for curbing the cardiovascular disease burden: a health priority in Sub-Saharan Africa. J Clin Hypertens (Greenwich) 2015; 17: 825–9.CrossRefGoogle ScholarPubMed
Kim, C, Seow, WJ, Shu, XO, et al. Cooking coal use and all-cause and cause-specific mortality in a prospective cohort study of women in Shanghai, China. Environ Health Perspect 2016; 124: 1384–9.CrossRefGoogle Scholar
Quansah, R, Semple, S, Ochieng, CA, et al. Effectiveness of interventions to reduce household air pollution and/or improve health in homes using solid fuel in low-and-middle income countries: a systematic review and meta-analysis. Environ Int 2017; 103: 7390.CrossRefGoogle ScholarPubMed
Pope, D, Bruce, N, Dherani, M, Jagoe, K, Rehfuess, E. Real-life effectiveness of “improved” stoves and clean fuels in reducing PM(2.5) and CO: systematic review and meta-analysis. Environ Int 2017; 101: 718.CrossRefGoogle Scholar
Elias, MF, Sullivan, LM, D'Agostino, RB, et al. Framingham stroke risk profile and lowered cognitive performance. Stroke 2004; 35: 404–9.CrossRefGoogle ScholarPubMed
Joosten, H, van Eersel, MEA, Gansevoort, RT, et al. Cardiovascular risk profile and cognitive function in young, middle-aged, and elderly subjects. Stroke 2013; 44: 1543–9.CrossRefGoogle ScholarPubMed

Send book to Kindle

To send this book to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats

Send book to Dropbox

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Dropbox.

Available formats